Development of all-in-one CRISPR/Cas9 and CRISPRi AAV constructs to treat autosomal dominant retinitis pigmentosa
<p>Dominant mutations in RHO (rhodopsin) are the most common cause of autosomal dominant retinitis pigmentosa (RHO-adRP). RHO-adRP causes progressive loss of rod cells, followed by cone cells, leading to blindness. This disease is a candidate for CRISPR gene editing, as reduction of mutant rho...
Κύριος συγγραφέας: | Peddle, CF |
---|---|
Άλλοι συγγραφείς: | MacLaren, RE |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
2021
|
Θέματα: |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
AAV-CRISPR/Cas9 Gene Editing Preserves Long-Term Vision in the P23H Rat Model of Autosomal Dominant Retinitis Pigmentosa
ανά: Saba Shahin, κ.ά.
Έκδοση: (2022-04-01) -
Genetic dissection of non-syndromic retinitis pigmentosa
ανά: Aarti Bhardwaj, κ.ά.
Έκδοση: (2022-01-01) -
Visual Acuity by Decade in 139 Males with RPGR-Associated Retinitis Pigmentosa
ανά: Samantha R. De Silva, DPhil, FRCOphth, κ.ά.
Έκδοση: (2024-03-01) -
Clinical and genetic features of Koreans with retinitis pigmentosa associated with mutations in rhodopsin
ανά: Young Hoon Jung, κ.ά.
Έκδοση: (2023-08-01) -
Stem cells set their sights on retinitis pigmentosa
ανά: Jeannette L Bennicelli, κ.ά.
Έκδοση: (2013-08-01)